USPSTF Statement on Screening for Type 2 Diabetes in Children, Adolescents

JAMA

EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, SEPTEMBER 13, 2022

Media advisory: To contact the U.S. Preventive Services Task Force, email the Media Coordinator at Newsroom@USPSTF.net or call 301-951-9203. The full report and related articles are linked to this news release.

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time and all USPSTF articles remain free indefinitely https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2022.14543?guestAccessKey=20b7ea1e-0bf0-40b1-9558-6f9566dde67e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=091322

 

Bottom Line: The U.S. Preventive Services Task Force (USPSTF) concludes that the current evidence is insufficient to make a recommendation about screening for type 2 diabetes in asymptomatic children and adolescents younger than age 18. The Centers for Disease Control and Prevention estimates that as of 2018 approximately 23,000 children and adolescents had type 2 diabetes, and data indicate that the incidence is rising. The USPSTF routinely makes recommendations about the effectiveness of preventive care services and has not previously released a recommendation on this topic.

 

(doi:10.1001/jama.2022.14543)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

Note: More information about the U.S. Preventive Services Task Force, its process, and its recommendations can be found on the newsroom page of its website.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.